They also expressed concern that the medical-marijuana initiative is overly broad in its authorizations for certifying a debilitating medical condition and that the only patients who should be certified are those who, in the physician's assessment, have "symptoms of spasticity, neuropathic pain, or other symptoms that are not optimally controlled with conventional medical therapy.